RUSSO, ANTONIO
 Distribuzione geografica
Continente #
EU - Europa 2.659
AS - Asia 1.181
NA - Nord America 950
SA - Sud America 173
AF - Africa 22
OC - Oceania 1
Totale 4.986
Nazione #
RU - Federazione Russa 2.056
US - Stati Uniti d'America 920
SG - Singapore 397
CN - Cina 249
IE - Irlanda 215
IT - Italia 175
HK - Hong Kong 155
VN - Vietnam 150
BR - Brasile 133
KR - Corea 72
GB - Regno Unito 47
JP - Giappone 46
DE - Germania 44
IN - India 44
FR - Francia 35
AR - Argentina 18
BD - Bangladesh 15
CA - Canada 13
GR - Grecia 12
PL - Polonia 12
ID - Indonesia 11
NL - Olanda 11
FI - Finlandia 10
IQ - Iraq 9
MX - Messico 9
AT - Austria 8
TR - Turchia 8
ES - Italia 7
EC - Ecuador 6
SE - Svezia 6
AZ - Azerbaigian 5
RS - Serbia 5
ZA - Sudafrica 5
CO - Colombia 4
PK - Pakistan 4
TN - Tunisia 4
UA - Ucraina 4
UZ - Uzbekistan 4
EG - Egitto 3
PE - Perù 3
PY - Paraguay 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
CD - Congo 2
DK - Danimarca 2
HN - Honduras 2
IR - Iran 2
LT - Lituania 2
MA - Marocco 2
RO - Romania 2
AL - Albania 1
AU - Australia 1
BE - Belgio 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GP - Guadalupe 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MY - Malesia 1
MZ - Mozambico 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PT - Portogallo 1
SA - Arabia Saudita 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 4.986
Città #
Moscow 767
Dublin 215
Singapore 191
Hong Kong 155
Santa Clara 155
San Jose 114
Ashburn 111
Seoul 72
Hefei 67
Ho Chi Minh City 49
Naples 43
Hanoi 39
The Dalles 36
New York 32
Bengaluru 29
Chandler 29
Caserta 23
Los Angeles 20
Beijing 18
Princeton 18
Roxbury 18
Cambridge 16
Bremen 15
Dallas 15
São Paulo 14
Washington 14
Da Nang 11
Munich 11
Amsterdam 9
Jacksonville 9
Warsaw 9
Chennai 8
London 8
Giugliano in Campania 7
Nuremberg 7
Orem 7
Boston 6
Jinan 6
Tokyo 6
Baku 5
Belgrade 5
Boardman 5
Brasília 5
Brooklyn 5
Bắc Ninh 5
Frankfurt am Main 5
Guastalla 5
Haiphong 5
Helsinki 5
Lappeenranta 5
Milan 5
Paris 5
Porto Alegre 5
Redwood City 5
Stockholm 5
Tianjin 5
Toronto 5
Atlanta 4
Biên Hòa 4
Campinas 4
Can Tho 4
Council Bluffs 4
Des Moines 4
Hillsboro 4
Istanbul 4
Johannesburg 4
Lucca 4
Tashkent 4
Vienna 4
Ariano Irpino 3
Aversa 3
Buenos Aires 3
Charlotte 3
Dhaka 3
Guangzhou 3
Juiz de Fora 3
Kingston 3
Lima 3
Ribeirão Preto 3
Rio Claro 3
Rio de Janeiro 3
Ankara 2
Asunción 2
Baghdad 2
Belo Horizonte 2
Bonea 2
Bắc Giang 2
Catanduva 2
Changsha 2
Changzhou 2
Chittagong 2
Clifton 2
Columbus 2
Curitiba 2
Damietta 2
Ercolano 2
Falkenstein 2
Formigine 2
Fortaleza 2
Greenville 2
Totale 2.591
Nome #
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 175
Abacavir hypersensivity reaction (HSR), associated to baseline false negative HLAB5701 screening, in antiretroviral treatment naive HIV-1 patient. 157
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 152
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 152
Cardiovascular system in COVID-19: Simply a viewer or a leading actor? 147
Delirium and Psychiatric Sequelae Associated to SARS-CoV-2 in Asymptomatic Patients With Psychiatric History and Mild Cognitive Impairment as Risk Factors: Three Case Reports 139
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? 135
Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study 134
An estimation of the prevalence of occult HBV infection in Western Europe and in Northern America: A meta-analysis 133
Directly acting antiviral-based treatment for hcv-infected persons who inject drugs: A multicenter real-life study 133
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 132
Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: A meta-analysis 129
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 128
Clinical Characterization of the Three Waves of COVID-19 Occurring in Southern Italy: Results of a Multicenter Cohort Study 125
Epidemiological and etiological variations in hepatocellular carcinoma 125
Different Clinical Outcomes of COVID-19 in Two Healthcare Workers Vaccinated with BNT162b2 Vaccine, Infected with the Same Viral Variant but with Different Predisposing Conditions for the Progression of the Disease 123
Efficacy of sotrovimab on omicron BA.2, BA.4 and BA.5 subvariants of sars-cov-2 vs. other early therapies: a systematic review and meta-analysis of literature data 116
Inappropriateness of Antibiotic Prescribing in Medical, Surgical and Intensive Care Units: Results of a Multicentre Observational Study 116
Risk of failure in dual therapy versus triple therapy in naïve HIV patients: a systematic review and meta-analysis 116
Efficacy and Tollerability of INI-Based 2-Drug Regimen in Virosuppressed Persons Living with HIV: A Systematic Review and Meta-Analysis 114
Impact of an education‐based antimicrobial stewardship program on the appropriateness of antibiotic prescribing: Results of a multicenter observational study 114
Assessment and Comparison of Two Serological Approaches for the Surveillance of Health Workers Exposed to SARS-CoV-2 113
Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study 112
Prognostic Value of Creatinine Levels at Admission on Disease Progression and Mortality in Patients with COVID-19-An Observational Retrospective Study 111
Blood donor serological screening for SARS-CoV-2 as a tool to estimate the prevalence of asymptomatic infection in a low-intermediate endemic area of southern Italy after the first wave of the pandemic 110
Innovative procedures for micro-elimination of HCV infection in persons who use drugs 110
Standard versus high dose of rifampicin in the treatment of pulmonary tuberculosis: a systematic review and meta-analysis 108
Obesity as a Risk Factor of Severe Outcome of COVID-19: A Pair-Matched 1:2 Case-Control Study 107
Clinical features of patients with home isolation SARS-COV-2 infection: A multicenter retrospective study in southern Italy 101
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial 100
Burden, risk assessment, surveillance and management of SARS-CoV-2 infection in health workers: A scoping review 100
Hbv/hdv co‐infection: Epidemiological and clinical changes, recent knowledge and future challenges 99
Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine 96
RISK OF FAILURE IN DUAL THERAPY VERSUS TRIPLE THERAPY IN NAÏVE HIV-PATIENTS: A META-ANALYSIS 95
Evaluation of Lipid Profile and Intima Media Thickness in Antiretroviral-Experienced HIV-Infected Patients Treated with Protease Inhibitor-Based Regimens versus Protease Inhibitor-Sparing Regimens 93
Pre-existing chronic kidney disease (CDK) was not associated with a severe clinical outcome of hospitalized COVID-19: results of a case-control study in Southern Italy 90
Current status of laboratory diagnosis for covid-19: A narrative review 89
Hepatitis C virus (HCV) micro-elimination in the hospital setting: The results of the HCV Caserta hospital project 87
Reazione di ipersensibilità ad abacavir associata a test HLAB5701 falsamente negativo al basale, in paziente HIV naive al trattamento antiretrovirale. 84
Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review 82
The SpO2/FiO2 Ratio Combined with Prognostic Scores for Pneumonia and COVID-19 Increases Their Accuracy in Predicting Mortality of COVID-19 Patients 81
Prevalence of occult HBV infection in Western countries 81
Prognostic Value of Transaminases and Bilirubin Levels at Admission to Hospital on Disease Progression and Mortality in Patients with COVID-19—An Observational Retrospective Study 71
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort 70
null 37
Clinical and epidemiological factors causing longer SARS-CoV 2 viral shedding: the results from the CoviCamp cohort 12
null 9
Clinical Evolution in COVID-19: Predictive Hematobiochemical Values, Monoclonal Antibody Effectiveness, and Long COVID Prognostic Factors 5
Totale 5.048
Categoria #
all - tutte 16.571
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.571


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 0 11 0
2021/202290 1 4 2 0 25 0 9 2 1 4 4 38
2022/2023335 23 6 6 6 45 28 2 10 178 6 11 14
2023/2024307 19 10 36 30 97 46 4 6 7 6 7 39
2024/2025784 1 11 8 31 125 112 118 61 150 47 76 44
2025/20263.424 190 255 177 120 336 1.904 181 106 107 48 0 0
Totale 5.048